Industry News

- Read more about Sun Pharma compeletes merger deal with Ranbaxy
Sun Pharmaceutical Industries Ltd. begins the integration of Ranbaxy’s business following the successful closure of its merger. The integration, planned by Sun Pharma over many months, will focus on supporting strong growth.
- Read more about Dr. Reddy’s starts new Center of Excellence for Fully Integrated Formulation Development Services
Dr. Reddy’s Custom Pharmaceutical Services (CPS) division has expanded its existing custom service facilities with a new formulation development laboratory in Miyapur, Hyderabad, India. Bringing together the existing API development team and the formulation teams at one location will accelerate project timelines, reduce costs and simplify licensing processes for CPS’ pharma customers.
- Read more about Novartis presents Cosentyx™ two-year efficacy and safety data showing sustainable effect in psoriasis patients
Novartis today announced new two-year results demonstrating sustained efficacy with Cosentyx™ (secukinumab) with an acceptable safety profile for the treatment of psoriasis patients. The data comes from the extension study of the pivotal Phase III FIXTURE and ERASURE trials. Results were presented for the first time in a late-breaking session at the 73rd Annual Meeting of the American Academy of Dermatology (AAD) in San Francisco. Cosentyx is the first and only interleukin-17A (IL-17A) antagonist approved to treat adult moderate-to-severe plaque psoriasis patients.

[adsense:336x280:8701650588]
- Read more about Emergent joins with GSK & NIAID for the production of Ebola Vaccine
Emergent BioSolutions under several agreements signed with the Oxford university, GSK and the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) respectively, it has manufactured a modified vaccinia Ankara (MVA) Ebola Zaire vaccine candidate (MVA EBOZ) anticipated for use in a Phase 1 clinical study to be conducted by Professor Adrian Hill of the Jenner Institute.
- Read more about Lupin fully acquires South African generic company
Pharmaceutical Major Lupin has entered into an agreement to acquire the balance 40% equity stake in South African generics major, Pharma Dynamics(PD) from its founders. As per the agreement, the founders will exercise their put option before March 31,2015, for the 40% equity stake it currently holds. On completion of this transaction, PD will become a wholly owned subsidiary of Lupin.
- Read more about Abbott's MitraClip® System Shown to Mend Hearts and Improve Lives in People in the United States
About three years ago, Betty Vaughn of Golden Valley, Minn., started to feel light-headed, fatigued and out of breath when she walked up and down the stairs. After visiting her doctor, the 89-year-old was diagnosed with degenerative mitral regurgitation (DMR), a heart condition in which the leaflets of the mitral valve do not close completely, causing blood to flow backward and leak into the left atrium of the heart.
- Read more about Mylan launched generic Subutex® & Antabuse® tablets in US
Mylan N.V. and Mylan Inc. announced the U.S. launch of Buprenorphine Hydrochloride Sublingual Tablets (2 mg and 8 mg) and Disulfiram Tablets USP (250 mg and 500 mg) which are the generic versions of Reckitt Benckiser's Subutex® Sublingual Tablets and Odyssey Pharmaceutical's Antabuse^® respectively.

[adsense:336x280:8701650588]
- Read more about Kiran Mazumdar-Shaw Honoured by Federation University Australia
(Business Wire India); Kiran Mazumdar-Shaw, Chairperson of Asia's premier biopharmaceutical enterprise Biocon Ltd., has been honoured by Federation University Australia (Fed Uni) by dedicating a road at the University’s Mt Helen Campus to her as ‘Mazumdar Drive’. She has also been appointed as an Ambassador of the University for a three-year term.

[adsense:336x280:8701650588]
- Read more about Chemfar Organics establishing ultra modern manufacturing facility for tablets & capsules around Bengaluru
A Pharmaceutical exporter, Chemfar Organics, establishing ultra modern manufacturing facility for tablets & capsules around Bengaluru, inviting partners for share participation.
- Read more about Sun Pharma announced to buy GSK’s Opiates business in Australia
GlaxoSmithKline (GSK) and Sun Pharmaceutical Industries Ltd. (Sun Pharma) announced that their respective wholly owned subsidiaries have reached an agreement related to GSK’s Opiates business in Australia.